The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab combined with anlotinib and chemotherapy (XELOX) in the treatment of advanced gastric carcinoma: Preliminary results of a single-arm, open-label phase I/IIa trial (TALENT study).
 
Xiaofeng Chen
No Relationships to Disclose
 
Deqiang Wang
No Relationships to Disclose
 
Yuan Yuan
No Relationships to Disclose
 
Jie Tang
No Relationships to Disclose
 
Fen Guo
No Relationships to Disclose
 
Yizhang Chen
No Relationships to Disclose
 
Junli Ding
No Relationships to Disclose
 
Tingting Hong
No Relationships to Disclose
 
Binbin Lu
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Rong Wang
No Relationships to Disclose
 
Yitong Tian
No Relationships to Disclose
 
Lanlan Pan
No Relationships to Disclose
 
Jiaguang Zhang
No Relationships to Disclose
 
Xinyi Zhang
No Relationships to Disclose
 
Tongpeng Xu
No Relationships to Disclose
 
Hao Xu
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose